NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $568,000 | -40.4% | 31,164 | +16.4% | 0.01% | -40.0% |
| Q2 2019 | $953,000 | -21.0% | 26,768 | -25.5% | 0.02% | -23.1% |
| Q1 2019 | $1,207,000 | -69.7% | 35,924 | -70.4% | 0.03% | -72.9% |
| Q4 2018 | $3,990,000 | -33.4% | 121,380 | +23.5% | 0.10% | -20.0% |
| Q3 2018 | $5,989,000 | +985.0% | 98,252 | +768.6% | 0.12% | +900.0% |
| Q2 2018 | $552,000 | +43.8% | 11,312 | +213.2% | 0.01% | +33.3% |
| Q1 2018 | $384,000 | -66.5% | 3,612 | -81.2% | 0.01% | -65.4% |
| Q4 2017 | $1,147,000 | +200.3% | 19,208 | +20.6% | 0.03% | +188.9% |
| Q3 2017 | $382,000 | +42.0% | 15,932 | +15.7% | 0.01% | +28.6% |
| Q2 2017 | $269,000 | +46.2% | 13,776 | +75.7% | 0.01% | +40.0% |
| Q1 2017 | $184,000 | +111.5% | 7,840 | +11.1% | 0.01% | +150.0% |
| Q4 2016 | $87,000 | – | 7,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |